Recombinant multi-species Secretogranin V/SCG5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Secretogranin V/SCG5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted chaperone protein that prevents the aggregation of other secreted proteins, including proteins that are associated with neurodegenerative and metabolic disease. The encoded protein may be best known for its role in the trafficking and activation of prohormone convertase PC2 (encoded by Gene ID: 5126). Phosphorylation of the encoded protein has been shown to have an inhibitory effect on its chaperone function. This gene also produces a ARHGAP11A-SCG5 readthrough transcript and ARHGAP11A-SCG5 protein. [provided by RefSeq, Feb 2019]
The Alternative Names of target: 7B2,Neuroendocrine protein 7B2,P7B2,Pituitary polypeptide,SCG5,SGNE1,Scg5,Secretogranin V,Secretogranin-5,Secretory granule endocrine protein I,SgV,Sgne-1,Sgne1

Target products collectionGo to Secretogranin V/SCG5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1262-Ag-1/ GM-Tg-hg-SE1262-Ag-2 Human Secretogranin V/SCG5 protein Human
GM-Tg-rg-SE1262-Ag-1/ GM-Tg-rg-SE1262-Ag-2 Rat Secretogranin V/SCG5 protein Rat
GM-Tg-mg-SE1262-Ag-1/ GM-Tg-mg-SE1262-Ag-2 Mouse Secretogranin V/SCG5 protein Mouse
GM-Tg-cynog-SE1262-Ag-1/ GM-Tg-cynog-SE1262-Ag-2 Cynomolgus/Rhesus macaque Secretogranin V/SCG5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1262-Ag-1/ GM-Tg-felg-SE1262-Ag-2 Feline Secretogranin V/SCG5 protein Feline
GM-Tg-cang-SE1262-Ag-1/ GM-Tg-cang-SE1262-Ag-2 Canine Secretogranin V/SCG5 protein Canine
GM-Tg-bovg-SE1262-Ag-1/ GM-Tg-bovg-SE1262-Ag-2 Bovine Secretogranin V/SCG5 protein Bovine
GM-Tg-equg-SE1262-Ag-1/ GM-Tg-equg-SE1262-Ag-2 Equine Secretogranin V/SCG5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1262-Ag-1/ GM-Tg-hg-SE1262-Ag-2; GM-Tg-rg-SE1262-Ag-1/ GM-Tg-rg-SE1262-Ag-2;
GM-Tg-mg-SE1262-Ag-1/ GM-Tg-mg-SE1262-Ag-2; GM-Tg-cynog-SE1262-Ag-1/ GM-Tg-cynog-SE1262-Ag-2;
GM-Tg-felg-SE1262-Ag-1/ GM-Tg-felg-SE1262-Ag-2; GM-Tg-cang-SE1262-Ag-1/ GM-Tg-cang-SE1262-Ag-2;
GM-Tg-bovg-SE1262-Ag-1/ GM-Tg-bovg-SE1262-Ag-2; GM-Tg-equg-SE1262-Ag-1/ GM-Tg-equg-SE1262-Ag-2
Products Name Secretogranin V/SCG5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Secretogranin V/SCG5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Secretogranin V/SCG5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.